← Oncology Approval Tracker

FDA DECISION ·

Lenalidomide (generic Revlimid)

lenalidomide · Natco Pharma

First generic approvalFirst genericHematologic malignancies
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

First generic Revlimid in 5, 10, 15 and 25 mg capsules. The FDA list includes multiple myeloma, transfusion-dependent anemia in a specified MDS population, mantle cell lymphoma, and previously treated follicular or marginal zone lymphoma.

LAMPGEN ANALYSIS

Why it matters

The approval opens an ANDA pathway for several established hematologic uses at the listed strengths.

What research teams should watch

Reconcile strength, renal dose adjustments and dispensing under the applicable risk management program.

PRIMARY RECORDS

Sources